Compare CTXR & INTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTXR | INTZ |
|---|---|---|
| Founded | 2007 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Communications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4M | 13.1M |
| IPO Year | 2010 | 2020 |
| Metric | CTXR | INTZ |
|---|---|---|
| Price | $0.51 | $0.27 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 253.3K | 204.3K |
| Earning Date | 12-22-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 43.38 | ★ 71.78 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $7,015,000.00 |
| Revenue This Year | N/A | $22.62 |
| Revenue Next Year | $104.18 | $26.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 21.56 |
| 52 Week Low | $0.37 | $0.32 |
| 52 Week High | $1.54 | $1.56 |
| Indicator | CTXR | INTZ |
|---|---|---|
| Relative Strength Index (RSI) | 48.05 | 28.02 |
| Support Level | $0.47 | N/A |
| Resistance Level | $0.63 | $0.89 |
| Average True Range (ATR) | 0.06 | 0.08 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 22.42 | 1.49 |
Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.
Intrusion Inc is a cybersecurity company based in Plano, Texas. The company offers its customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its platform combines threat intelligence, malicious traffic identification, and automated threat response, and is designed to help organizations proactively identify and stop malicious activity in their networks. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company operates in single segment.